Bone Marrow Transplant for CML Patients in India is generally considered for selected patients with chronic myeloid leukemia (CML), particularly when targeted medicines do not provide adequate disease control, when the disease progresses to an advanced phase, or when other treatment options are unsuitable. For international patients from Nigeria, Kenya, Ghana, Zimbabwe, Cameroon, Guyana, Jamaica, the Middle East, Europe and the USA, India offers specialised haematology and stem-cell transplant services with comparatively lower treatment costs. However, a transplant is not usually the first treatment for newly diagnosed chronic-phase CML. Tyrosine kinase inhibitors (TKIs) are commonly used first, and transplant decisions require individual assessment by a specialist.
HeyDocta supports international patients with medical opinions, hospital coordination, treatment-cost estimates, medical visa guidance, travel assistance and follow-up planning.
Get a Free Medical Opinion: Share your CML reports with HeyDocta to understand potential treatment options and whether a transplant evaluation in India may be appropriate.
Why International Patients Consider India for CML Treatment
CML management requires specialised haematology care, molecular monitoring and access to advanced treatment when the disease becomes difficult to control.
International patients may consider India for:
- Specialist haematology and bone marrow transplant teams
- BCR::ABL1 molecular monitoring and advanced diagnostics
- Targeted therapy and stem-cell transplant services
- Multidisciplinary cancer care
- Comparatively lower treatment costs
- International patient coordination
- Medical visa and travel assistance
- Post-treatment follow-up planning
The appropriate hospital depends on the patient’s disease phase, previous treatment, response to TKIs, transplant eligibility and specialist assessment.
What Is CML?
Chronic myeloid leukemia (CML) is a blood cancer associated with the BCR::ABL1 abnormality, commonly resulting from the Philadelphia chromosome. The disease is generally classified into chronic, accelerated and blast phases.
Modern CML treatment has changed significantly with the development of targeted medicines. NCI lists BCR::ABL1-targeted TKIs including imatinib, dasatinib, nilotinib, bosutinib and asciminib among treatment options.
Is Bone Marrow Transplant Necessary for Every CML Patient?
No. Allogeneic stem-cell transplantation is not routinely required for newly diagnosed chronic-phase CML.
For many patients, treatment begins with a TKI and regular molecular monitoring. Transplant may become relevant when there is inadequate response, intolerance or resistance to appropriate TKI treatment, or when CML progresses to an advanced phase.
NCI states that allogeneic stem-cell transplantation may be considered in chronic-phase CML and is an important treatment option in accelerated and blast-phase disease.
The transplant decision considers:
- CML phase
- Response to TKI therapy
- BCR::ABL1 molecular response
- Previous treatments
- Patient age and general health
- Donor availability
- Risks associated with transplantation
Bone Marrow Transplant Specialist for CML in India
Dr. Gaurav Dixit at Artemis Hospitals, Gurugram is Head – Haematology Oncology & Bone Marrow Transplant. His listed specialties include BMT, haematopoietic stem-cell transplantation, haematology and oncology. Artemis lists chronic myeloid leukemia (CML) among his areas of expertise, along with AML, ALL, MDS, lymphoma and multiple myeloma.
His listed procedures include:
- Matched sibling allogeneic stem-cell transplant
- Haploidentical stem-cell transplant
- Matched unrelated donor transplant
- Autologous stem-cell transplant
- CAR-T cell therapy
Artemis also lists a dedicated BMT division providing stem-cell transplantation services for malignant and non-malignant blood disorders.
Bone Marrow Transplant Cost for CML in India
The bone marrow transplant cost for CML in India depends mainly on the type of transplant, donor source, conditioning regimen, hospital stay, medicines, blood products and complications.
Some Hospitals currently gives a general BMT cost range of USD15000 to 30000, noting that costs vary according to hospital, location, room category and complications.
For 2026 planning, an India-focused transplant cost guide estimates approximately USD 20,800–36,400 for matched-related allogeneic transplantation and USD 31,200–57,200+ for haploidentical, unrelated-donor or complex transplant pathways. These are planning ranges rather than fixed CML treatment packages.
CML Bone Marrow Transplant Cost: India vs USA
| Country | Indicative Cost | Key Cost Factors |
| India | General BMT:USD15000 to 30000 | Hospital, donor type, medicines and complications |
| India – matched-related allogeneic | Approx. USD 20,800–36,400 | Donor evaluation, conditioning and transplant care |
| India – complex/alternative donor | Approx. USD 31,200–57,200+ | Donor procurement, complications and prolonged care |
| USA | USD 240,000 to over USD 1 million for unrelated transplant and up to 6 months of care | Donor search and extended post-transplant care |
The U.S. Health Resources & Services Administration reports that an unrelated bone marrow or cord-blood transplant can range from USD 240,000 to more than USD 1 million, including the transplant and up to six months of care. Donor-search costs can also be additional.
These figures are not direct package-to-package comparisons because hospitals and healthcare systems may include different services.
What Affects the Total CML Transplant Cost?
The final quotation may depend on:
- Type of transplant
- Matched sibling, haploidentical or unrelated donor
- HLA testing and donor work-up
- CML disease status
- Previous TKI and other treatments
- Conditioning therapy
- Stem-cell collection and processing
- Hospitalisation and protective isolation
- Blood and platelet transfusions
- Antibiotics and other medicines
- Infection management
- Graft-versus-host disease treatment
- ICU care, if required
- Post-transplant monitoring
International patients should also budget for flights, accommodation, caregiver expenses and local transportation.
Talk to Our Medical Tourism Expert: HeyDocta can coordinate with suitable Indian hospitals to help patients obtain a personalised medical opinion and treatment-cost estimate.
Hospitals for CML Treatment and Bone Marrow Transplant in India
International patients can explore haematology and BMT services at:
- Artemis Hospitals
- Fortis Hospitals
- Max Hospitals
- Manipal Hospitals
- Yatharth Hospitals
- Sarvodaya Hospital
- Yashoda Hospitals
The right hospital should be selected according to the patient’s CML phase, treatment history, molecular response, transplant requirement and specialist availability rather than a generic hospital ranking.
CML Bone Marrow Transplant Process in India
Step 1: Medical Records Review
Patients can share CBC reports, BCR::ABL1 PCR results, bone-marrow reports, cytogenetic findings, previous treatment records and TKI history.
Step 2: Specialist Consultation
A haematologist reviews the disease phase, treatment response and previous therapies to determine whether continued targeted therapy or transplant evaluation is appropriate.
Step 3: Molecular and Disease Assessment
BCR::ABL1 testing and other investigations help assess the patient’s response and disease status.
Step 4: Donor Evaluation
If allogeneic transplant is recommended, HLA testing is performed to identify a suitable donor.
Step 5: Pre-Transplant Assessment
The patient undergoes evaluation of organ function, infections, blood counts and other factors that influence transplant eligibility.
Step 6: Conditioning Treatment
The selected conditioning regimen is administered before stem-cell infusion.
Step 7: Stem-Cell Infusion
Donor stem cells are administered through an intravenous line following conditioning. The cells subsequently migrate to the bone marrow and begin blood-cell production.
Step 8: Engraftment and Monitoring
The patient remains under close observation while blood counts recover. Infection prevention, transfusion support, medicines and monitoring are important during this period.
Step 9: Long-Term Follow-Up
After discharge, continued haematology follow-up is necessary. International patients should coordinate ongoing care with their Indian transplant team and home-country specialist.
Medical Visa and Travel Support
Eligible international patients can apply for India’s e-Medical Visa. The official Indian e-Visa portal requires a letter from the concerned Indian hospital stating the proposed admission/treatment details for an e-Medical Visa application.
HeyDocta can assist with:
- Hospital appointment coordination
- Medical invitation documentation
- Visa guidance
- Airport and local travel planning
- Accommodation assistance
- Caregiver coordination
- Follow-up appointment planning
Recovery and Stay After CML Transplant
Allogeneic stem-cell transplantation is an intensive treatment. The initial hospital stay and subsequent local stay vary according to conditioning, engraftment, infections, graft-versus-host disease and other complications.
Patients should not schedule an early return flight without clearance from the treating transplant team. Blood counts may recover before the immune system fully recovers, meaning continued medical monitoring can be required after discharge.
Frequently Asked Questions
1. Is bone marrow transplant the first treatment for CML?
Usually not for newly diagnosed chronic-phase CML. Targeted BCR::ABL1 TKIs are commonly used initially. Transplant may be considered in selected patients with inadequate treatment response, resistance, intolerance or advanced disease.
2. What type of transplant is used for CML?
When transplantation is appropriate, allogeneic stem-cell transplantation using donor cells is generally the relevant approach for CML.
3. How much does CML bone marrow transplant cost in India?
General BMT costs are reported around USD15000–30000, while matched-related allogeneic pathways may be approximately USD 20,800–36,400 and complex donor pathways can be higher. The final quotation depends on the individual treatment plan.
4. Can international CML patients travel to India for treatment?
Eligible international patients can travel to India for medical treatment subject to Indian visa requirements and medical suitability. A specialist review should be completed before travel.
5. How long does recovery take after CML transplant?
Recovery varies considerably. Hospitalisation and close local monitoring may continue for several weeks, while immune recovery can take substantially longer.
6. Can HeyDocta arrange a treatment-cost estimate?
Yes. Patients can share their medical records with HeyDocta, which can coordinate with suitable partner hospitals for medical opinions and estimated treatment costs.
7. Does HeyDocta charge an additional coordination fee?
HeyDocta provides medical tourism facilitation, hospital coordination, visa guidance and travel assistance without an additional service charge to patients for its facilitation support. Patients remain responsible for hospital treatment, medicines, investigations, travel, accommodation and other actual expenses.
Conclusion
Bone Marrow Transplant for CML Patients in India is an important treatment consideration for selected patients, but it is not necessary for every person with CML. Modern CML management commonly begins with targeted therapy, while allogeneic stem-cell transplantation may be considered when the disease does not respond adequately to available therapies, becomes resistant or progresses to an advanced phase.
India provides specialised haematology and transplant services and can offer comparatively lower treatment costs than countries such as the USA. However, transplant suitability, cost, donor requirements and recovery vary from patient to patient.
HeyDocta supports international patients from Africa, the Middle East, Europe, the USA and the Caribbean with medical opinion coordination, hospital selection support, treatment-cost estimates, visa guidance, travel assistance and follow-up planning.
Get Treatment Cost from Indian Hospitals: Share your CML medical reports with HeyDocta.com to discuss suitable treatment options, transplant evaluation and estimated treatment costs in India.
